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PHeart Rhythm Disorders
Paroxysmal Lone Atrial Fibrillation Is
Associated With an Abnormal Atrial Substrate
Characterizing the “Second Factor”
Martin K. Stiles, MB, CHB, PHD, Bobby John, MD, PHD, Christopher X. Wong,
Pawel Kuklik, PHD, Anthony G. Brooks, PHD, Dennis H. Lau, MBBS, Hany Dimitri, MBBS,
Kurt C. Roberts-Thomson, MBBS, PHD, Lauren Wilson, BSC, Paolo De Sciscio, BSC,
Glenn D. Young, MBBS, Prashanthan Sanders, MBBS, PHD
Adelaide, Australia
Objectives The purpose of this study was to determine whether patients with paroxysmal “lone” atrial fibrillation (AF) have
an abnormal atrial substrate.
Background While “AF begets AF,” prompt termination to prevent electrical remodeling does not prevent disease progression.
Methods Twenty-five patients with paroxysmal lone AF, without arrhythmia in the week prior, and 25 reference patients
with left-sided accessory pathways were studied. Multipolar catheters placed at the lateral right atrium (RA),
crista terminalis, coronary sinus, septal RA, and sequentially within the left atrium (LA) determined the effective
refractory period (ERP) at 10 sites, conduction time along linear catheters, and conduction characteristics at the
crista terminalis. Bi-atrial electroanatomic maps were created to determine regional differences in conduction
velocity and voltage.
Results Patients with AF demonstrated the following compared with reference patients: larger atrial volumes (RA: 94 
18 ml vs. 69  9 ml, p  0.003; LA: 99  19 ml vs. 77  17 ml, p  0.006); longer ERP (at 600 ms: 255 
25 ms vs. 222  16 ms, p  0.001; at 450 ms: 234  20 ms vs. 212  14 ms, p  0.004); longer conduction
time along linear catheters (57  18 ms vs. 47  10 ms, p  0.01); longer bi-atrial activation time (128  17
ms vs. 89  10 ms, p  0.001); slower conduction velocity (RA: 1.3  0.3 mm/ms vs. 2.1  0.5 mm/ms; LA:
1.2  0.2 mm/ms vs. 2.2  0.4 mm/ms, p  0.001); greater proportion of fractionated electrograms (27  8%
vs. 8  5%, p  0.001); longer corrected sinus node recovery time (265  57 ms vs. 185  60 ms, p  0.002);
and lower voltage (RA: 1.7  0.4 mV vs. 2.9  0.4 mV; LA: 1.7  0.7 mV vs. 3.3  0.7 mV, p  0.001).
Conclusions Patients with paroxysmal lone AF, remote from arrhythmia, demonstrate bi-atrial abnormalities characterized by
structural change, conduction abnormalities, and sinus node dysfunction. These factors are likely contributors to
the “second factor” that predisposes to the development and progression of AF. (J Am Coll Cardiol 2009;53:
1182–91) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.11.054c
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atrial fibrillation (AF) arises as a result of a complex
nteraction of triggers, perpetuators, and substrate (1).
xperimental studies of AF have demonstrated shortening
f the effective refractory period (ERP) and slowing of
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April 7, 2009:1182–91 Abnormal Substrate in Lone AFation of arrhythmia (7,8). However, strategies of prompt
ermination of AF to avoid this cycle of adverse remodeling
ave failed to show benefit (9). In fact, the natural history of
aroxysmal AF is one of increasing frequency and duration of
pisodes (10). These observations have led to the search for a
second factor” integral to the development and progression of
F (11).
See page 1192
We hypothesized that patients with paroxysmal “lone”
F have an abnormal atrial substrate that determines
isease progression. In order to evaluate the substrate
redisposing to AF, free of the electrical remodeling
ffects of the arrhythmia itself, we evaluated the electro-
hysiological and electroanatomic characteristics of atria in
atients with paroxysmal “lone” AF, remote in time from
rrhythmia.
ethods
tudy population. This study comprised 25 patients un-
ergoing first-time ablation for paroxysmal AF and a
eference group of 25 patients with structurally normal
earts undergoing radiofrequency ablation for atrioventric-
lar re-entry tachycardia with left-sided accessory pathways
nd no history of AF. A total of 215 consecutive highly
ymptomatic patients undergoing AF ablation procedures
ere screened to obtain the 25 fulfilling the study criteria.
atients for the study group were excluded if they had AF
uring the week before ablation (established by continuous
onitoring) or any of the criteria that would prohibit the
iagnosis of “lone” AF, previously defined as the absence of
tructural heart disease or stroke based on history, physical
xamination, chest X-ray, routine blood chemistry, and
ransthoracic as well as transesophageal echocardiography
10,12,13). Coronary artery disease was excluded by clinical,
lectrocardiogram (ECG), or stress test criteria. Pulmonary
isease, hypertension, hyperthyroidism, and diabetes were
liminated by appropriate tests. Paroxysmal AF was defined
ccording to the expert consensus statement as recurrent AF
hat terminates spontaneously within 7 days (14).
All antiarrhythmic medication was ceased 5 half-lives
efore the study. No patient had received amiodarone or
igoxin. All patients provided written informed consent to the
tudy protocol, which was approved by the Human Research
thics Committee of the Royal Adelaide Hospital.
lectrophysiological study and ablation. Electrophysi-
logical study was performed in the post-absorptive state
ith sedation utilizing midazolam and fentanyl. In patients
ith AF, the study protocol was performed before ablation,
hile in the reference group this was done after accessory
athway ablation. The left atrium (LA) was accessed using
single transseptal puncture after which repeated bolus
nfractionated heparin was utilized to maintain the acti-
ated clotting time between 300 to 350 s. iAfter the study protocol, pa-
ients with AF underwent circum-
erential pulmonary vein ablation
ith an end point of isolation con-
rmed by circumferential mapping
Lasso, Biosense-Webster, Dia-
ond Bar, California) with ei-
her elimination or dissociation
f pulmonary venous potentials.
blation of the pulmonary veins
as performed using a delivered
ower of 30 W with irrigation
ates of 30 ml/min (Thermocool,
iosense-Webster). Additional
ubstrate modification was per-
ormed in patients with an episode of AF 48 h or with
n LA size 57 mm (longest diameter). This took the
orm of linear ablation along the LA roof with an end
oint of conduction block demonstrated by linear double
otentials and an activation detour during pacing of the
A appendage. Cavo-tricuspid isthmus ablation with an
nd point of bidirectional isthmus block was performed
nly in patients with a history of typical flutter or if
apping confirmed typical flutter during the procedure.
inear ablation was performed with a delivered power of
0 to 35 W with irrigation rates of 30 to 60 ml/min.
tudy protocol. ELECTROPHYSIOLOGY STUDY. The follow-
ng catheters were positioned for the study protocol: 1) a
0-pole catheter (2-5-2 mm interelectrode spacing, Daig
lectrophysiology, Minnetonka, Minnesota) within the
oronary sinus with the proximal bipole at the coronary
inus ostium as determined in the best septal left anterior
blique position; 2) a 20-pole “crista” catheter (1-3-1 mm
nterelectrode spacing, Biosense-Webster) placed along the
rista terminalis with the distal tip superiorly such that the
econd bipole lay at the junction of the superior vena cava
nd right atrium (RA), stabilized by a long sheath (CSTA,
aig Electrophysiology) to ensure close apposition to this
tructure; 3) a 20-pole catheter (2-5-2 mm interelectrode
pacing, Daig Electrophysiology) placed along the lateral
A; and 4) a roving 10-pole catheter (2-5-2 mm interelec-
rode spacing, Biosense-Webster) positioned within the LA
ia transseptal puncture. This catheter was stabilized with
he use of a long sheath (Preface, Biosense-Webster or SL0,
aig Electrophysiology) and sequentially positioned as
ollows at the: 1) LA roof; 2) inferior LA; 3) midposterior
A; 4) LA appendage; and 5) high RA septum, as previ-
usly described (15). Electrophysiological evaluation was
erformed as detailed in the following text.
FFECTIVE REFRACTORINESS. Atrial ERP was evaluated at
wice diastolic threshold at cycle lengths of 600 and 450 ms
sing an 8-beat drive followed by an extrastimulus, starting
ith a coupling interval of 150 ms increasing in 10-ms
ncrements. ERP was defined as the longest coupling
Abbreviations
and Acronyms
AF  atrial fibrillation
CI  confidence interval
CSNRT  corrected sinus
node recovery time
ERP  effective refractory
period
LA  left atrium/atrial
OR  odds ratio
RA  right atrium/atrial
SACT  sinoatrial
conduction timenterval failing to propagate to the atrium. At each site the
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Abnormal Substrate in Lone AF April 7, 2009:1182–91RP was measured 3 times at each cycle length and
veraged. If ERP varied by 10 ms, an additional 2
easurements were made and the total number averaged.
RP was measured from the following sites: 1) distal
oronary sinus; 2) proximal coronary sinus; 3) low-lateral
A; 4) high-lateral RA; 5) high-septal RA; 6) LA append-
ge; 7) midposterior LA; 8) inferior LA; 9) junction of left
uperior pulmonary vein with LA roof; and 10) junction of
ight superior pulmonary vein with LA roof. Heterogeneity
f ERP was determined by the coefficient of variation of
RP at each cycle length (SD/mean  100%). AF induced
y ERP testing lasting 5 min was considered sustained;
hen this occurred, no further data were acquired.
TRIAL CONDUCTION. Atrial conduction time was assessed
long linearly placed catheters by pacing the distal bipole
1,2) and determining the conduction time to a proximal
ipole (9,10) at the LA roof, inferior LA, coronary sinus,
nd lateral RA. Conduction time at each site was averaged
ver 10 beats during stable capture at 600 and 450 ms cycle
engths. P-wave duration was determined as a marker of global
onduction by the average of 10 beats on ECG lead II.
ITE-SPECIFIC CONDUCTION ABNORMALITIES AT THE CRISTA
ERMINALIS. The number of bipoles on the crista terminalis
atheter with discrete double potentials separated by an
soelectric interval or complex fractionated activity of 50
s duration and the maximum electrogram duration were
etermined during sinus rhythm, constant pacing and for
he shortest-coupled captured extra-stimulus from the prox-
mal coronary sinus, low-lateral RA, inferior LA, and LA
ppendage.
INUS NODE FUNCTION. Sinus node function was evaluated
s follows: 1) baseline sinus cycle length was determined
ver 10 consecutive sinus cycles; 2) sinoatrial conduction
ime (SACT) was determined after an 8-beat pacing train
sing the formula (SACT  [return  basic cycle length]/2)
times and averaged; and 3) corrected sinus node recovery
ime (CSNRT) was determined after a 30-s drive train at
ycle lengths of 600 and 450 ms, correcting for the baseline
ycle length. At each cycle length, CSNRT was determined
times and averaged.
lectroanatomic mapping. Electroanatomic maps were
reated of both atria during sinus rhythm using the
ARTO mapping system and a 3.5-mm tip catheter
Navistar, Biosense-Webster). The electroanatomic map-
ing system has been previously described in detail; the
ccuracy of the sensor position has been previously validated
nd is 0.8 mm and 5° (16). In brief, the system records the
urface ECG and bipolar electrograms filtered at 30 to 400
z from the mapping and reference catheters. Endocardial
ontact during point acquisition was facilitated by electro-
ram stability, fluoroscopy, and the catheter icon on the
ARTO system. Points were acquired in the auto-freeze
ode if the stability criteria in space (6 mm) and localctivation time (5 ms) were met. Mapping was performed dith an equal distribution of points using a fill-threshold of
5 mm. Editing of points was performed offline. Local
ctivation time was manually annotated to the peak of
he largest amplitude deflection on bipolar electrograms; in
he presence of double potentials, this was annotated at the
argest potential. If the bipolar electrogram displayed equiv-
lent maximum positive and negative deflections, the max-
mum negative deflection on the simultaneously acquired
nipolar electrogram was used to annotate the local activa-
ion time. Points not conforming to the surface ECG
-wave morphology or 75% of the maximum voltage of
he preceding electrogram were excluded. Regional atrial
ipolar voltage and conduction velocity were analyzed as
reviously described and are detailed in the following text
15,17–19).
OLTAGE ANALYSIS. For the purposes of evaluating regional
oltage differences, each atrium was segmented using pre-
iously validated offline software (20). The RA was seg-
ented as the high- and low-lateral RA, high- and low-
osterior RA, high- and low-septal RA, and anterior RA.
he LA was segmented as posterior LA, anterior LA, septal
A, inferior LA, lateral LA, and LA roof. The voltage of
oints identified by region was then exported for analysis.
ow voltage points were defined as point with a bipolar
oltage 0.5 mV and electrically silent points (scar) as the
bsence of recordable activity or a bipolar voltage amplitude
0.05 mV (the noise level of the system).
ONDUCTION VELOCITY ANALYSIS. Isochronal activation maps
5-ms intervals) of the atria were created and regional conduc-
ion velocity determined in the direction of the wave-front
ropagation (least isochronal crowding). An approximation of
onduction velocity was determined by expressing the distance
etween 2 points as a function of the difference in local
ctivation time. Mean conduction velocity for each region was
etermined by averaging the conduction velocity between 5
airs of points, as previously described (15,17–19). For the
urposes of evaluating regional conduction differences, each
trium was segmented as noted in the preceding text.
OMPLEX ELECTROGRAMS. The proportion of points dem-
nstrating complex electrograms was determined using the
ollowing definitions: 1) fractionated signals: complex activ-
ty of 50 ms duration; and 2) double potentials: potentials
eparated by an isoelectric interval where the total electro-
ram duration was 50 ms.
tatistical analysis. Continuous variables are reported as
ean  SD or median and interquartile range as appropri-
te. Categorical variables are reported as number and
ercentage. Proportions were compared using the Fisher
xact test. Comparisons between means were analyzed using
aired or unpaired t tests as appropriate. Comparisons with
djustment for multiple sampling within patients were
erformed using a mixed linear model for continuous data
r a logistic generalized estimating equation for categorical
ata. Statistical tests were performed using SPSS version 15
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April 7, 2009:1182–91 Abnormal Substrate in Lone AFSPSS Inc., Chicago, Illinois), and statistical significance
as set at a value of p  0.05.
esults
aseline details. Baseline patient characteristics are sum-
arized in Table 1. Groups were well matched for age, sex,
eft ventricular wall thickness, and function. However,
atients with AF had significantly larger LA (p  0.001).
one of the patients with AF had atrial arrhythmias (30 s)
y continuous monitoring in the 7 days before the procedure.
trial refractoriness. For patients with AF, the mean ERP
cross all sites was greater than that of reference patients (at
00 ms: 255  25 ms vs. 222  16 ms, p  0.001; at 450
s: 234  20 ms vs. 212  14 ms, p  0.004). Figure 1
emonstrates the ERP at the 10 sites tested after 600 and 450
s drive trains in patients with AF versus reference patients,
nd indicates those areas where significant differences were
een. The differences in ERP between patients with AF and
eference patients were not uniform across all sites (p  0.02).
t each site, patients with AF demonstrated either an increase
r no significant change in ERP when compared with the
eference group. The ERP was longer after a 600-ms drive
rain than after a 450-ms drive train for both patients with AF
p  0.001) and reference patients (p  0.02); that is, there
as preservation of physiological rate-adaptation of ERP in
oth groups (p  0.1). Heterogeneity of refractoriness, as
easured by the coefficient of variation of ERP, did not differ
etween groups: at 600 ms 12 5% versus 13 3% (p 0.6)
nd at 450 ms 13  5% versus 13  4% (p  1.0).
trial conduction time. The conduction time along the
atheters at the LA roof, inferior LA, coronary sinus, and
ateral RA was significantly longer in patients with AF
ompared with that seen in the reference group (57 18 ms
s. 47  10 ms, p  0.01). However, there was no
ignificant interaction between patient group and site of
onduction measurement (p  0.3), suggesting a homoge-
ous slowing of conduction in patients with AF.
The P-wave duration was significantly prolonged in
atients with AF compared with that in reference patients
128  8 ms vs. 95  10 ms, p  0.001).
ite-specific conduction abnormalities. Site-specific con-
uction abnormalities at the crista terminalis during sinus
hythm were more apparent in patients with AF than
aseline Characteristics
Table 1 Baseline Characteristics
AF
(n  25)
Reference
(n  25) p Value
Age (yrs) 53 8 49 9 0.2
Male sex (%) 80 60 0.2
Median AF history (months) 60 0 N/A
Longest AF duration (days) 3.0 2.2 0 N/A
Left atrial parasternal size (mm) 41 7 34 4 0.001
Interventricular septum (mm) 11 2 11 1 0.6
Left ventricular ejection fraction (%) 55 9 58 7 0.7hF  atrial fibrillation.eference patients. During sinus rhythm, patients with AF
ad a greater number of bipoles demonstrating double
otentials or fractionated signals on the crista terminalis
atheter than reference patients (4.9  1.8 vs. 0.7  0.8,
 0.001) of which the maximum electrogram duration
as longer (84  15 ms vs. 52  11 ms, p  0.001). These
ifferences were more marked during pacing and with
xtrastimulus (p  0.001), as illustrated in Figure 2, which
escribes the extent of conduction abnormalities depending
n the rate and site of stimulation.
inus node function. Patients with AF had a longer
aseline sinus cycle length (975 131 ms vs. 762 129 ms,
 0.001), SACT (154  58 ms vs. 83  31 ms, p 
.001), and CSNRT at 600 ms (265  57 ms vs. 185  60
s, p  0.002) but not 450 ms (261  96 ms vs. 241  76
s, p  0.6) compared with reference patients.
lectroanatomic mapping. A total of 193  62 points per
atient were analyzed in the LA and RA using electroana-
omic mapping.
tructural and voltage abnormalities. Both RA and LA
olumes by electroanatomic mapping were significantly
reater in patients with AF compared with those seen in
eference patients (RA: 94  18 ml vs. 69  9 ml, p 
.003; LA: 99  19 ml vs. 77  17 ml, p  0.006).
The mean bipolar voltage was reduced in patients with
F compared with that in reference patients (RA: 1.7 0.4
V vs. 2.9 0.4 mV; LA: 1.7 0.7 mV vs. 3.3 0.7 mV,
 0.001). The difference in mean log bipolar voltage
etween patients with AF and reference patients varied
ignificantly by mixed linear model according to the region
f measurement (RA: p  0.002; LA: p  0.03). Regional
ifferences in bipolar voltage with significant differences
ndicated are illustrated in Figure 3. Additionally, points in
atients with AF at the high-lateral RA, posterior LA, and
he LA roof were more likely to be low voltage (0.5 mV)
odds ratio [OR]: 2.9, 95% confidence interval [CI]: 1.4 to
.3; OR: 1.7, 95% CI: 1.1 to 2.6; and OR: 3.3, 95% CI: 1.8
o 6.3, respectively). No significant areas of electrical scar
0.05 mV) were observed in this cohort of patients.
epresentative examples of electroanatomic maps in repre-
entative patients are shown in Figure 4.
bnormalities in conduction velocity. Patients with AF
ad a significantly slower mean conduction velocity during
inus rhythm compared with reference patients (RA: 1.3 
.3 mm/ms vs. 2.1 0.5 mm/ms; LA: 1.2 0.2 mm/ms vs.
.2  0.4 mm/ms, p  0.001). Regional differences in
onduction velocity with significant differences indicated are
llustrated in Figure 5. The total atrial activation time was
ignificantly prolonged in patients with AF compared with
hat in reference patients (128  17 ms vs. 89  10 ms,
 0.001).
omplex electrograms. Patients with AF demonstrated a
ignificantly greater number of points with double potentials
r fractionated signals than reference patients (27  8% vs.
 5%, p  0.001). Patients with AF were more likely toave a point with a double potential or fractionated signal in
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Abnormal Substrate in Lone AF April 7, 2009:1182–91ny region than reference patients (p  0.02). These points
ere distributed throughout both atria with a clustering at
he high-posterior and -septal regions of the RA, and the
A septum and roof (Fig. 4).
iscussion
ajor findings. This study utilized electrophysiological
nd electroanatomic mapping to demonstrate new informa-
ion on the nature of abnormalities within the atria of
atients with paroxysmal “lone” AF, remote from an ar-
hythmic event. The major findings are as follows:
. Structural abnormalities characterized by atrial dilation
and lower mean atrial voltage, suggesting the loss of
atrial myocardium;
. Conduction abnormalities, characterized by prolonga-
AF
Reference
dCS pCS LLRA HLRA H
m
s
300
275
250
225
200
175
dCS pCS LLRA HLRA H
m
s
300
275
250
225
200
175
Figure 1 Regional Effective Refractoriness
Mean (SD) effective refractory period at the 10 sites tested after a 600-ms drive
and reference patients. All values for 600 ms are longer than the same patient gr
between patients with AF and reference patients varied significantly according to t
†p  0.01; ‡p  0.05 for post-hoc comparisons (unadjusted). dCS  distal coron
inferior left atrium; LAA  left atrial appendage; LLRA  low lateral right atrium; LS
nary sinus; PostLA  posterior left atrium; RSPV  junction of right superior pulmtion of conduction times, longer P-wave duration, islower conduction velocity, site-specific conduction de-
lay, and an increase in the proportion of complex
electrograms;
. Impaired sinus node function; and
. An increase in ERP consistent with prior studies eval-
uating clinical substrates for AF but in contrast to the
remodeling attributed to AF itself.
hus, the present study suggests that patients with paroxysmal
one AF have an abnormal atrial substrate. We posit that these
bnormalities are essential contributors to the “second factor”
hat promotes progression of AF and why sinus rhythm does not
eget sinus rhythm in patients with AF.
ate-related electrical remodeling. The seminal observa-
ions by Wijffels et al. (3) that “AF begets AF” has as its
entral tenet the observation of reduction in atrial ERP by
epeated induction of AF thereby allowing AF to sustain
600ms
LSPV RSPV InfLA LAA PostLA
450ms
LSPV RSPV InfLA LAA PostLA
(top) and a 450-ms drive train (bottom) in patients with atrial fibrillation (AF)
d site value for 450 ms. The difference in mean effective refractory period
ion of measurement (p  0.02 for group by region interaction). *p  0.001;
us; HLRA  high lateral right atrium; HRAS  high right atrial septum; InfLA 
junction of left superior pulmonary vein with left atrium; pCS  proximal coro-
ein with left atrium.RAS
RAS
train
oup an
he reg
ary sin
PV 
onary vtself. Many experimental studies have confirmed this find-
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April 7, 2009:1182–91 Abnormal Substrate in Lone AFng (2,4,6,21,22). While these initial studies fail to observe
ny conduction abnormalities, subsequent studies by Gaspo
t al. (5) demonstrated that progressively longer episodes of
F also resulted in conduction slowing. Thus, the electrical
emodeling of the atria in response to AF results in the
erpetuation of arrhythmia by a shortening of the re-entrant
wavelength.” In addition, several investigators have also
bserved remodeling of the sinus node that develops soon
fter the initiation of arrhythmia and reverses after restora-
ion of sinus rhythm (13,22,23).
Interestingly, despite the early occurrence and reversible
hanges in electrical remodeling of the atria in response to
ate, Ausma et al. (24) have observed that ultrastructural
hanges evolve over a much longer time frame and are not
ompletely resolved as late as 4 months after return to sinus
hythm. These slow-to-resolve alterations have been char-
cterized as an increase in myolysis and the fraction of
xtracellular matrix per myocyte, as well as changes in the
xpression of structural proteins.
Clinical studies have also observed similar effects of rate
n the atria. Patients with recent AF have been shown to
ave shorter ERP than the control groups, as well as sinus
ode dysfunction and conduction delay (13,25). Yu et al. (8)
emonstrated shorter ERP with impaired rate adaptation
pCS LLRA InfLA LAA
1
2
3
4
5
6
7
8
1
2
3
4
5
6
7
8 S2
S1
p<0.001
p<0.001
1
1
1
m
1
1
1
m
Number
pCS LLRA InfLA LAA
Figure 2 Conduction Characteristics at the Crista Terminalis
Mean (SD) number (left) and maximum duration (right) of double potentials or f
the earliest captured extrastimulus (S2) from 4 sites in the atria in patients with a
Abbreviations as in Figure 1.nd depressed conduction after cardioversion for long- standing AF, with the ERP gradually increasing after 4 days
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aroxysmal and persistent AF at their ablation procedure
nd demonstrated a reduction in ERP at 3 sites and
onduction slowing compared with that seen in patients
ith no AF. In this study, patients with persistent AF had
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aroxysmal AF had a mean AF burden of 3.2 3.7 h in the
receding 72 h. Recent studies in patients with AF under-
oing ablation have demonstrated the presence of areas of
ow voltage and scar (27,28), and have implicated this
ubstrate as a marker of a worse outcome after an ablation
rocedure (29). However, with the known experimental
vidence of rate-related remodeling, it is unclear if the
bnormalities observed in these patients with AF form the
nderlying substrate for arrhythmia or whether they are
ndeed a consequence of the arrhythmia itself.
rogression of AF. Garratt et al. (11) evaluated the effect
f repeated episodes of AF on atrial electrical remodeling.
hile marked remodeling was observed with 5 days of AF,
days of sinus rhythm was adequate to reverse all abnor-
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ailed to prevent the progression to more AF. Indeed, their
ndings suggest that sinus rhythm does not beget sinus
hythm in patients with a history of AF.
These findings have led the laboratory/group of Allessie
11) to propose the existence of a “second factor” for the
nitial substrate and subsequent progression of AF. To
dentify this factor, we studied patients with paroxysmal
one AF who were remote from an episode of AF (thereby
emoving the effects of acute rate-related remodeling).
hen studied distant from an arrhythmic event, patients
ith lone AF demonstrated an increase in atrial refractori-
ess, widespread and site-specific conduction abnormalities,
nd evidence of sinus node remodeling, which were associ-
ted with structural changes.
We posit that these changes in structure and conduction
een in lone paroxysmal AF, remote from arrhythmia, repre-
ent essential contributors to the “second factor,” which has an
mportant role in the development and progression of AF.
ubstrate predisposing to the development of AF. Al-
hough the abnormalities that have been observed to result
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pment of AF in the first place. This has led several
nvestigators to evaluate the atrial abnormalities in condi-
ions predisposed to the development of AF.
Li et al. (30) developed a canine model of congestive heart
ailure to evaluate effects on atrial remodeling and demon-
trated “atrial remodeling of a different sort” from that seen due
o AF alone. A significant increase in ERP at short cycle
engths associated with an increase in the heterogeneity of
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ndings by demonstrating significant electroanatomic re-
odeling with areas of low voltage and electrical scar in
ssociation with prolonged ERP with widespread and site-
pecific conduction abnormalities in patients with conges-
ive heart failure and sinus node disease. Kistler et al. (19)
emonstrated such changes in a progressive manner with
ncreasing age. While these findings have been restricted to
he RA, recently similar manifestations have been observed
n the LA in patients with mitral stenosis (15).
In patients with AF, there is a paucity of clinical mapping
hat has been performed outside the context of recent arrhyth-
ia. In order to minimize the confounding effects of electrical
emodeling, we have undertaken meticulous screening to
dentify patients who were in sinus rhythm for a minimum of
Figure 4 Example Electroanatomic Bipolar Voltage Maps
Representative CARTO maps of a patient with atrial fibrillation (bottom) and a refe
of the same scale. The color scale is identical in both images with red representin
regions of low voltage (red), the patient with atrial fibrillation has more evidence o
potentials (blue tags).days before their ablation procedure. Indeed, of 215 consec- ltive procedures performed on highly symptomatic patients
resenting for ablation of AF, only 25 were suitable to be
tudied. Using such stringent enrollment criteria, the observa-
ions of the current study are remarkably consistent with the
ndings observed in the above conditions on the substrate
redisposing to AF. Taken together, these studies provide
ompelling evidence that the predominant contributors to the
ubstrate underlying AF are the structural and associated
onduction abnormalities rather than changes in refractoriness.
revious studies implicating abnormalities in “lone”
F. Although patients with lone AF are defined as a group
ith no structural heart disease, there is accumulating
vidence of occult abnormalities. Frustaci et al. (33) found
bnormal atrial histology including patchy fibrosis and
nflammatory infiltrates in all of 12 patients with paroxysmal
patient (top). Both atria are oriented in the posterior-anterior projection and are
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ype I in patients with lone AF compared with that seen in
eference subjects, and this increase has been observed to
e attenuated in those patients receiving angiotensin-
onverting enzyme inhibitors (34). There is further evidence
hat inflammation plays a role in AF, with the observation
hat C-reactive protein is elevated in patients with lone AF
35). Jaïs et al. (12) have demonstrated by transseptal
emodynamic evaluation that diastolic dysfunction is
resent in patients with lone AF. Finally, there is some
vidence to suggest that patients with lone AF have micro-
ascular dysfunction in the coronary circulation (36). Thus,
t is feasible that patients without overt structural heart
isease may have fibrosis, inflammation, structural change,
nd vascular dysfunction, all features that are consistent
ith and contribute to our observations of an abnormal
ubstrate in lone AF.
mplications. The electrical remodeling seen in conjunc-
ion with ongoing arrhythmia and thought to perpetuate AF
s known to normalize within days of sinus rhythm (11).
owever, strategies of repeated cardioversion have not been
uccessful in retarding progression of disease (9). By study-
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Mean (SD) conduction velocity in the 7 RA and 6 LA regions from the electroanang patients remote in time from the arrhythmia itself, we pave been able to show that the predominant underlying
ubstrate in patients with AF is structural change is associ-
ted with conduction slowing, perhaps accounting for the
rogression of the AF disease. Future strategies to treat AF
hould, therefore, focus on atrial myocardial structure and
onduction. Finally, while pulmonary vein isolation is cur-
ently considered to be highly successful for the majority of
atients with paroxysmal AF, there is not yet definitive
ong-term data on outcome. This study showing an abnor-
al substrate in lone AF raises the possibility of progressive
isease continuing despite early procedural success.
tudy limitations. While the abnormalities observed in
his study are proposed to constitute the substrate predis-
osing to AF, the development of clinical AF is complex
nd depends not only on substrate but also on other factors
uch as triggers and perpetuators that were not addressed by
his study. Patients with persistent AF were not studied and
ay differ in substrate; however, many patients with persis-
ent AF start with paroxysms initially. Finally, while we
onitored patients for a week before the procedure to
nsure our evaluation was remote from an episode of AF, we
annot exclude an effect of rate-related remodeling from
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emodeling within days (11).
onclusions
atients with paroxysmal lone AF, remote from an arrhyth-
ic episode, demonstrate structural abnormalities charac-
erized by loss of myocardial voltage, conduction slowing,
ltered sinus node function, and prolonged atrial refracto-
iness. These abnormalities contribute to the “second factor”
ritical to the development and progression of AF.
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